FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to gynaecology, and can be used for dynamic control of treatment of cervical intraepithelial lesions of cervix uteri. For this purpose after application of medication based on active substance 3,3'-diindolylmethane in dosage form "vaginal suppositories" in dose 200 mg/day for 6 months efficiency of therapy with application of colposcopic methods is assessed after 6 and 12 months of therapy.
EFFECT: method makes it possible to reliably assess therapy efficiency and speed of onset of therapeutic effect.
4 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING OF PLANOCELLULAR INTRAEPITHELIAL LESIONS OF CERVIX OF UTERUS | 2014 |
|
RU2552332C1 |
| METHOD OF COMBINED THERAPY OF CERVICAL DYSPLASIA ASSOCIATED WITH HUMAN PAPILLOMA VIRUSES | 2019 |
|
RU2701525C1 |
| 3,3'-DIINDOLYLMETHANE (METINDOL)-BASE VAGINAL SUPPOSITORY | 2006 |
|
RU2318510C1 |
| METHOD FOR COMBINED TREATMENT OF PATIENTS WITH HPV-ASSOCIATED CERVICAL SQUAMOUS INTRAEPITHELIAL LESIONS CIN II-III | 2023 |
|
RU2819504C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DYSPLASTIC PROCESSES OF CERVIX | 2008 |
|
RU2395281C2 |
| METHOD FOR TREATMENT OF CERVICAL INTRAEPITHELIAL GRADE I NEOPLASIA ASSOCIATED WITH HPV OF HIGH ONCOGENIC RISK, USING A CAVITATED SOLUTION OF PANAVIR | 2017 |
|
RU2682783C2 |
| MEDICINAL AGENT IN FORM OF COMPLEX OF 3,3'-DIINDOLYLMETHANE AND β-CYCLODEXTRIN, METHOD FOR PREPARING THEREOF AND METHOD OF TREATING CERVICAL NEOPLASIA USING THEREOF | 2020 |
|
RU2738658C1 |
| METHOD OF TREATING HPV ASSOCIATED CERVICAL NEOPLASIAS II-III DEGREE | 2015 |
|
RU2585423C1 |
| METHOD OF CHOOSING TACTICS OF MANAGING PATIENTS WITH CERVICAL NEOPLASIA | 2011 |
|
RU2472424C1 |
| METHOD FOR DETERMINING MANAGEMENT OF PATIENTS WITH MODERATE DYSPLASTIC CHANGES IN CERVIX UTERI | 2019 |
|
RU2704798C1 |
